Scientific Associate III

The University Health Network, where “above all else the needs of patients come first”, encompasses Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre, Toronto Rehabilitation Institute and the Michener Institute of Education. The breadth of research, the complexity of the cases treated, and the magnitude of its educational enterprise has made UHN a national and international resource for patient care, research and education. With a long tradition of ground breaking firsts and a purpose of “Transforming lives and communities through excellence in care, discovery and learning”, the University Health Network (UHN), Canada’s largest research teaching hospital, brings together over 16,000 employees, more than 1,200 physicians, 8,000+ students, and many volunteers. UHN is a caring, creative place where amazing people are amazing the world.

Position Summary
Our research seeks to ambitiously lead the next technology driven innovation cycle of engineered cell therapies against genitourinary cancers. To accomplish this, we systematically apply high-content, multi-gene targeting CRISPR screens to patient-derived humanized models of cancer to identify strategies for improving response to therapy. We have a particular focus on employing locoregional or “surgically” delivered cell-based therapies against localized aggressive cancers, with the goal of developing minimally invasive, organ sparing, curative alternatives to currently existing ineffective radical (e.g. surgery) treatments. Our work resides within the intersection of surgery, engineering, immunology and genetics, providing a highly collaborative, stimulating and multidisciplinary ecosystem to conduct research within.

We are seeking a highly motivated and accomplished PhD-level Research Associate to lead our dynamic team focused on functional genomic strategies for improving surgically delivered cell therapies targeting genitourinary malignancies. The successful candidate will not only drive research efforts but also play a crucial role in supervising and mentoring PhD students and post-doctoral researchers. This position offers a unique opportunity to contribute to ground-breaking discoveries that have the potential to revolutionize the treatment of genitourinary cancers.

Duties

UHN uses email to communicate with selected candidates. Please ensure you check your email regularly.

Please be advised that a Criminal Record Check may be required of the successful candidate. Should it be determined that any information provided by a candidate be misleading, inaccurate or incorrect, UHN reserves the right to discontinue with the consideration of their application.

All UHN Employees are required to be fully vaccinated with a COVID-19 vaccine series, approved by Health Canada or the World Health Organization, as a condition of hire. Proof of COVID-19 vaccination will be required. Should you be the successful candidate, you will be required to comply with UHN’s mandatory Vaccination Policy that is in effect.

UHN is an equal opportunity employer committed to an inclusive recruitment process and workplace. Requests for accommodation can be made at any stage of the recruitment process. Applicants need to make their requirements known.

We thank all applicants for their interest, however, only those selected for further consideration will be contacted.